{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreib6gdjfigy2zq6osws4lodkzqc7bodljjyfabmywphe5ftk2tysv4",
    "uri": "at://did:plc:k7h5fn3kdhjpj37pc6yhno2o/app.bsky.feed.post/3mgtild63qgc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreig4rqzd7n2e7yxijsra52gulh6uo6bz3kjlcak4sqcty3k5vhajoy"
    },
    "mimeType": "image/jpeg",
    "size": 83803
  },
  "path": "/article/the-fda-approves-leucovorin-for-rare-genetic-condition-and-not-for-autism/",
  "publishedAt": "2026-03-11T15:00:00.000Z",
  "site": "https://www.scientificamerican.com",
  "textContent": "The FDA on Tuesday approved leucovorin as a treatment for a rare genetic condition, not for autism, as the Trump administration had suggested",
  "title": "The FDA approves leucovorin for rare genetic condition and not for autism"
}